Late changes in hemostatic parameters following open-heart surgery. 1982

F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri

Changes in hemostatic parameters following open-heart surgery with cardiopulmonary bypass were studied in twelve patients for two postoperative weeks. No clinical manifestations of hemostatic abnormalities were found in these patients throughout the study period. The prothrombin time and activated partial thromboplastin time were within normal limits. The platelet counts and fibrinogen levels were depleted on the first postoperative day, followed by a rapid return to above normal levels within 7 days. The fibrinogen/fibrin degradation products (FDP) showed a peak elevation on the first day, followed by a gradual decline. In 92% of the patients, the FDP levels became elevated to more than 10 micrograms/ml. Rate of the increase in FDP level was closely reflected by the amount of postoperative blood loss when the loss exceeded 10 ml/kg of body weight during 48 hours postoperatively. The levels of plasmin inhibitors (alpha 1-antitrypsin and alpha 2-macroglobulin) were also measured. the alpha 1 antitrypsin was elevated during the postoperative period. The alpha 2-macroglobulin showed no significant changes. In summary, the hemostatic changes following open-heart surgery included activation of the fibrinolytic system and depletion of coagulation factors immediately after surgery, followed by hypercoagulability due to a rapid return to above normal levels of coagulation factors and plasmin inhibitors. We consider, however, these changes to be part of the homeostatic response following open-heart surgery.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
November 1976, RN,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
June 1976, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
March 1992, Annals of Saudi medicine,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
January 1984, Khirurgiia,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
February 1967, Archives of general psychiatry,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
December 1975, Undersea biomedical research,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
August 1977, The Annals of thoracic surgery,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
October 2005, The Thoracic and cardiovascular surgeon,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
January 1986, Scandinavian journal of thoracic and cardiovascular surgery,
F Mori, and Y Nakahara, and S Kurata, and S Furukawa, and K Esato, and H Mohri
January 1978, The Mount Sinai journal of medicine, New York,
Copied contents to your clipboard!